WHO ICTRP trial
A randomized, double-blind, single-center, placebo-controlled…
ChiCTR1900020919 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900020919 |
|---|---|
| Public title | A randomized, double-blind, single-center, placebo-controlled, parallel-controlled clinical trial for umbilical cord mesenchymal stem cell injection for the treatment of inhaled lung injury |
| Scientific title | A randomized, double-blind, single-center, placebo-controlled, parallel-controlled clinical trial for umbilical cord mesenchymal stem cell injection for the treatment of inhaled lung injury |
| Primary sponsor | Changhai Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | I+II (Phase I+Phase II) |
| Countries | China |
| Conditions | Inhalation lung injury |
| Interventions | High dose group:2×10^8 cells/10mL;Medium dose group:1×10^8 cells/10mL;Low dose group:0.5×10^8 cells/10mL ;Placebo group:0 cells/10mL |
| Registration date | Jan 22, 2019 |
| Target size | High dose group:8;Medium dose group:8;Low dose group:8;Placebo group:8 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: